Versican expression in myoepithelial cells from carcinomas in canine mixed mammary tumors

Veterinary Journal

Volumn 200, Issue 1, 2014, Pages 146-151

  Damasceno, Karine A ^a   Bertagnolli, Angélica C ^b   Estrela Lima, Alessandra ^c   Rabelo, Bruna S ^a   Campos, Liliane C ^a   Ribeiro, Lorena G R ^c   Cassali, Geovanni D ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Desidério Finamor Veterinary Research Institute FEPAGRO   (Brazil)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Canine; Chondrogenesis; Mixed mammary tumor; Myoepithelial cell; Versican

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GLYCOSAMINOGLYCAN; PROTEIN P63; PROTEOGLYCAN; PROTEOGLYCAN SULFATE; UNCLASSIFIED DRUG; VERSICAN; ACTIN; PHOSPHOPROTEIN; PROTEOCHONDROITIN SULFATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANINE MIXED MAMMARY TUMOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DOG; FEMALE; GENETIC ASSOCIATION; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MYOEPITHELIUM CELL; NONHUMAN; PERIODIC ACID SCHIFF STAIN; PHENOTYPE; PROTEIN EXPRESSION; SAFRANINO STAINING; SPINDLE CELL; STAINING; TUMOR GROWTH; ANIMAL; DOG DISEASE; EPITHELIUM CELL; EXPERIMENTAL MAMMARY NEOPLASM; GENE EXPRESSION; GENETICS; METABOLISM; MYOEPITHELIOMA; PATHOLOGY;

ACTINS; ANIMALS; CELL DIFFERENTIATION; CHONDROITIN SULFATE PROTEOGLYCANS; DOG DISEASES; DOGS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GLYCOSAMINOGLYCANS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, ANIMAL; MYOEPITHELIOMA; PHOSPHOPROTEINS; VERSICANS;

EID: 84898821926     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2014.01.013     Document Type: Article

References (34)

1. Akiyoshi T., Uchida K., Tateyama S. Expression of bone morphogenetic protein-6 and bone morphogenetic protein receptors in myoepithelial cells of canine mammary gland tumors. Veterinary Pathology 2004, 41:154-163.
2. Arai K., Uehara K., Naoi M. Simultaneous expression of type IX collagen and an inhibin-related antigen in proliferative myoepithelial cells with pleomorphic adenoma of canine mammary glands. Japanese Journal of Cancer Research 1995, 86:577-584.
3. Auler P., Bertagnolli A., Ferreira E., Campos G., Dias A.P., Campos C., Campos L., Cassali G. Myeloid metaplasia in canine mixed mammary tumors: Occurrence and characterization. Veterinary Quarterly 2011, 31:173-177.
4. Bertagnolli A.C., Cassali G.D., Genelhu M.C.L.S., Costa F.A., Oliveira J.F.C., Gonçalves P.B.D. Immunohistochemical expression of p63 and △ Np63 in mixed tumors of canine mammary glands and its relation with p53 expression. Veterinary Pathology 2009, 46:407-415.
5. Buijs, J T., Cleton A.M., Smit V.T.H.B., Löwik C.W.G.M., Papapoulos S.E., van der Pluijm G. Prognostic significance of periodic acid-Schiff-positive patterns in primary breast cancer and its lymph node metastases. Breast Cancer Research and Treatment 2004, 84:117-130.
6. Cassali, G.D., Melo, B.M., Madureira, N., Ferreira, E., Bertagnolli, A.C., Ribeiro, G.M., Campos, C.B., 2009. Mammary gland diagnosis of the Laboratory of Comparative Pathology - UFMG, from 2000 to 2008. 34 World Small Animal Veterinary Association Congress, São Paulo. Clínica Veterinária 14, 173.
7. Caterson B., Mahmoodian F., Sorrell J.M., Hardingham T.E., Bayliss M.T., Carney S.L., Ratcliffe A., Muir H. Modulation of native chondroitin sulphate structure in tissue development and in disease. Journal of Cell Science 1990, 97:411-417.
8. Damasceno K.A., Bertagnolli A.C., Estrela-Lima A., Ribeiro L.G.R., Rabelo B.S., Campos C.B., Barros A.L.B., Cassali G.D. Versican expression in canine carcinomas in benign mixed tumours: Is there an association with clinical pathological factors, invasion and overall survival?. BMC Veterinary Research 2012, 8:195.
9. Destexhe E., Lespagnard M., Degeyter M., Heyman R., Coignoul F. Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors. Veterinary Pathology 1993, 30:146-154.
10. Erdélyi I., Nieskens D.H.M., van Dijk J.E., Vass L., Nederbragt H. Immunohistochemical evaluation of versican, in relation to chondroitin sulphate, in canine mammary tumors. Histology and Histopathology 2003, 18:1067-1080.
11. Erdelyi I., van Asten A.J.A.M., van Dijk J.E., Nederbragt H. Expression of versican in relation to chondrogenesis-related extracellular matrix components in canine mammary tumors. Histochemical and Cell Biology 2005, 124:139-149.
12. Erichsen S. A histochemical study on mixed tumours of the canine mammary gland. Acta Pathologica et Microbiologica Scandinavica 1955, 36:490-502.
13. Gama A., Alves A., Gartner F., Schmitt F. P63: A novel myoepithelial cell marker in canine mammary tissues. Veterinary Pathology 2003, 40:412-440.
14. Gärtner F., Geraldes M., Cassali G., Rema A., Schmitt F. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumors: Putative evidence for a common histogenesis. Veterinary Pathology 1999, 158:39-47.
15. Hellmén E. Complex mammary tumours in the female dog: A review. Journal of Dairy Research 2005, 72:90-97.
16. Hinrichs U., Rutteman G.R., Nederbragt H. Stromal accumulation of chondroitin sulphate in mammary tumours of dogs. British Journal of Cancer 1999, 80:1359-1365.
17. Kischel P., Waltregny D., Dumont B., Turtoi A., Greffe Y., Kirsch S., Pauw E.D., Castronovo V. Versican overexpression in human breast cancer lesions: Known and new isoforms for stromal tumor targeting. International Journal of Cancer 2010, 126:640-650.
18. Kusafuka K., Ishiwata T., Sugisaki Y., Takemura T., Kusafuka M., Hisha H., Ikehara S. Lumican expression is associated with the formation of mesenchyme-like elements in salivary pleomorphic adenomas. Journal of Pathology 2004, 203:953-960.
19. Kusafuka K., Muramatsu K., Kasami M., Kuriki K., Hirobe K., Hayashi I., Watanabe H., Hiraki Y., Shukunami C., Mochizuki T., Kameya T. Cartilaginous features in matrix-producing carcinoma of the breast: Four cases report with histochemical and immunohistochemical analysis of matrix molecules. Modern Pathology 2008, 21:1282-1292.
20. Lewis J.E., Olsen K.D., Sebo T.J. Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases. Human Pathology 2001, 32:596-604.
21. Liotta L.A., Kohn E.C. The microenvironment of the tumor-host interface. Nature 2001, 411:375-379.
22. Los Monteros A.E., Millán M.Y., Ramírez G.A., Ordás J., Reymundo C., De Las Martín., Mulas J. Expression of Maspin in mammary gland tumours of the dog. Veterinary Pathology 2005, 42:250-257.
23. Misdorp, W., Else, R.W., Hellmén, E., Lipscomb, T.P., 1999. Histological Classification of Mammary Tumors of the Dog and Cat. WHO International Histological Classification Tumors of Domestic Animals, Second Series. Armed Forces Institute of Pathology, Washington, pp. 18-27.
24. Moulton J.E. Tumors of the mammary gland. Tumors in Domestic Animals 1990, 518-552. University of California Press, Berkeley, CA. Third Ed. J.E. Moulton (Ed.).
25. Pukkila M.J., Kosunen A.S.T., Virtaniemi J.A., Kumpulainen E.J., Johansson R.T., Kellokoski J.K., Nuutinen J., Kosma V.M. Versican expression in pharyngeal squamous cell carcinoma: An immunohistochemical study. Journal of Clinical Pathology 2004, 57:735-739.
26. Pulley L.T. Ultrastructural and histochemical demonstration of myoepithelium in mixed tumors of the canine mammary gland. American Journal of Veterinary Research 1973, 34:1513-1522.
27. Ramalho L.N.Z., Ribeiro-Silva A., Cassali G.D., Zucoloto S. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms. Veterinary Pathology 2006, 43:424-429.
28. Skandalis S.S., Labropoulou V.T., Ravazoula P., Likaki-Karatza E., Dobra K., Kalofonos H.P., Karamanos N.K., Theocharis A.D. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. BMC Cancer 2011, 11:1-13.
29. Tateyama S., Uchida K., Hidaka T., Hirao M., Yamaguchi R. Expression of bone morphogenetic protein-6 (BMP-6) in myoepithelial cells in canine mammary gland tumors. Veterinary Pathology 2001, 38:703-709.
30. Voz M.L., Van De Ven W.J., Kas K. First insight into the molecular basis of pleomorphic adenomas of the salivary glands. Advances in Dental Research 2000, 14:81-83.
31. Willems S.M., Wiweger M., van Roggen J.F.G., Hogendoorn P.C.W. Running GAGs: Myxoid matrix in tumor pathology revisited: What's in it for the pathologist?. Virchows Archiv 2010, 456:181-192.
32. Wu Y., Chen L., Cao L., Sheng W., Yang B.B. Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and β1-integrin. Journal of Cell Science 2004, 117:2227-2237.
33. Yee A.J.M., Akens M., Yang B.L., Finkelstein J., Zheng P.S., Deng Z., Yang B. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis. Breast Cancer Research 2007, 9:1-11.
34. Zheng P.S., Wen J., Ang L.C., Sheng W., Viloria-Petit A., Wang Y., Wu Y., Kerbel R.S., Yang B.B. Versican/PG-M G3 domain promotes tumor growth and angiogenesis. The FASEB Journal 2004, 18:754-756.